
The availability of new zzso agents has zzso the treatment timeline for advanced zzso and increases the likelihood of receiving chemotherapy near zzso Use of chemotherapy near the end of life may not benefit cancer zzso However, no zzso study has examined the zzso for continuing chemotherapy at the end of life for all ages and cancer groups as well as for a whole zzso This zzso study assessed the association between continuation of chemotherapy in the last month of life and patient zzso disease zzso primary zzso specialty, hospital zzso and zzso resource availability at the hospital and regional zzso 

zzso zzso cohort study using administrative data among 204 zzso Taiwanese cancer zzso in zzso 

Rates of continued chemotherapy in the last month of life for each study year were zzso zzso zzso zzso zzso and zzso respectively and have remained steady since zzso Taiwanese cancer patients had greater odds for continuation of chemotherapy in the last month of life if they were male zzso odds ratio zzso zzso zzso confidence zzso zzso zzso younger, single zzso zzso had lower zzso levels, were diagnosed with zzso zzso zzso zzso and breast cancer zzso zzso had zzso disease zzso zzso and survived zzso 1 year but longer than two months zzso The odds for continued chemotherapy in patients' last month was significantly increased by being cared for by a medical zzso zzso zzso or in a teaching hospital zzso zzso and with the highest intensity of total zzso hospital beds zzso zzso but was not influenced by regional zzso resources zzso hospital and hospice zzso 

The relative risk for continuation of chemotherapy in the last month of life was determined by patient demographics and disease zzso physician specialty, and zzso resources at the primary hospital zzso 

